Calumet Crescita futura
Criteri Future verificati 3/6
Si prevede che Calumet aumenterà gli utili e i ricavi rispettivamente del 134.5% e 5% all'anno, mentre si prevede che l'EPS crescerà del 83.9% all'anno.
Informazioni chiave
134.5%
Tasso di crescita degli utili
83.90%
Tasso di crescita dell'EPS
| Oil and Gas crescita degli utili | 10.7% |
| Tasso di crescita dei ricavi | 5.0% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Good |
| Ultimo aggiornamento | 24 Apr 2026 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Aggiornamento dell'analisi • Apr 30
CLMT: Shreveport Restart And Higher Margin Outlook Will Support Bullish Case
Analysts have adjusted their price target on Calumet to $60.00. The latest update reflects revised views on discount rate, revenue growth, profit margins and future P/E assumptions.Aggiornamento dell'analisi • Apr 15
CLMT: Shreveport Recovery And Improved Outlook Will Support Higher Future P/E
Analysts have lifted their fair value estimate for Calumet from $33.00 to $60.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple. What's in the News Calumet reported an operational update for the first quarter of 2026 after identifying organic chlorides in feedstock tanks at its Shreveport facility.
Aggiornamento dell'analisi • Apr 01
CLMT: Projected 2025 Losses And Rich P/E Will Pressure Future Returns
Analysts have kept their Calumet price target at $25.00, citing a slightly lower discount rate, more measured expectations for revenue growth and profit margins, and a higher assumed future P/E multiple as key inputs behind the unchanged valuation. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million based on preliminary data (Key Developments).Aggiornamento dell'analisi • Mar 18
CLMT: Expected 2025 Losses Will Continue To Weigh On Returns
Analysts have raised their price target on Calumet from $19.00 to $25.00 per share, citing updated assumptions that include a lower discount rate, revised revenue growth expectations, higher profit margin estimates, and an adjusted future P/E multiple. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million (Key Developments).Aggiornamento dell'analisi • Mar 04
CLMT: Lower Margin Assumptions And Expected 2025 Losses Will Restrain Returns
Narrative Update on Calumet The analyst fair value estimate for Calumet has been reset from $13.25 to $19.00. Analysts point to updated assumptions around discount rates, revenue growth, profit margins, and future P/E as key drivers of the new target range.
Aggiornamento dell'analisi • Feb 18
CLMT: Expected 2025 Net Loss Will Sustain Bearish Equity Repricing
Analysts have nudged their price target on Calumet up by $0.80 to $23.45, reflecting updated assumptions around discount rates, profit margins and future P/E expectations. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, based on preliminary data (Key Developments).Articolo di analisi • Feb 05
Calumet, Inc. (NASDAQ:CLMT) Stock Rockets 26% But Many Are Still Ignoring The Company
Calumet, Inc. ( NASDAQ:CLMT ) shareholders have had their patience rewarded with a 26% share price jump in the last...Aggiornamento dell'analisi • Feb 03
CLMT: Future Loss Guidance And Production Trends Will Support Fair Pricing
Analysts have raised their fair value estimate for Calumet from $21.45 to $22.65, citing updated assumptions around discount rates, revenue growth, profit margins and a future P/E of about 31.81x. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range of $69.0 million to $12.0 million based on preliminary data (Key Developments).Aggiornamento dell'analisi • Jan 20
CLMT: Future Loss Guidance And Steady Production Will Support Fair Pricing
Analysts have kept their fair value estimate for Calumet steady at US$21.45, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions driving this unchanged price target. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million, based on preliminary data (Key Developments).Seeking Alpha • Jan 16
Calumet: Specialty Products' Businesses Coming Together Financially
Summary Calumet Specialty Products is executing a transformative strategy, with EBITDA projected to nearly double in 2026 and potentially triple by 2028. CLMT's integrated specialty, traditional refining, and renewable fuels businesses are aligning, supported by industry-leading cost structures and expanding SAF production capacity. We forecast 2026 EBITDA of $525–$550 million, up from $300 million in 2025, driven by SAF margin expansion and operational improvements. I rate CLMT a buy around $20, citing strong earnings growth potential, improving capital structure, and credible execution on renewables. Read the full article on Seeking AlphaAggiornamento dell'analisi • Jan 06
CLMT: Lower Margin Outlook Will Restrain Returns Despite Higher Production
Analysts have revised their price target on Calumet to US$13.25 from US$13.25, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that reshape how they view the balance between the company’s earnings potential and the risk investors are taking on. What's in the News Calumet issued earnings guidance for the year ended December 31, 2025, indicating an expected net loss in a range of US$69.0 million to US$12.0 million, based on preliminary data (company guidance).Aggiornamento dell'analisi • Dec 17
CLMT: Softer Margins And Slower Revenue Expansion Will Limit Upside Potential
Analysts have modestly trimmed their price target on Calumet to $13.25. This reflects slightly lower expectations for revenue growth and profit margins, even as a reduced discount rate and a marginally higher future P/E multiple continue to support the valuation.Aggiornamento dell'analisi • Dec 03
CLMT: Future Profit Margins Will Improve While Shares Remain Fairly Valued
Analysts have nudged their price target on Calumet shares higher to reflect modestly improved discount rate and valuation assumptions, and now see fair value as essentially unchanged near 21.45 dollars despite slightly more favorable risk and earnings profiles. What's in the News Reported third quarter 2025 total facility production of 88,668 bpd, up from 83,305 bpd in the prior year period (company operating results announcement).Aggiornamento dell'analisi • Nov 19
CLMT: Future Profit Margins Will Improve With Lower RIN Liabilities
Analysts have raised their price target for Calumet from $20.25 to $21.45, citing improved revenue growth projections and greater profit margin expectations as key drivers behind the updated valuation. What's in the News Calumet reported a rise in total facility production to 88,668 barrels per day for the third quarter of 2025, up from 83,305 barrels per day during the same period last year (Announcement of Operating Results).Aggiornamento dell'analisi • Nov 05
CLMT: Future Outlook Balances EPA Exemptions With Reduced RIN Liabilities
Analysts have raised their price target for Calumet from $19.25 to $20.25, citing improved margin expectations and a lower perceived discount rate, even though growth forecasts have been slightly reduced. What's in the News Calumet received an update from the EPA confirming that all of its small refinery exemption petitions filed from 2019 through 2024 have been granted either full or partial exemptions (Key Developments).Aggiornamento dell'analisi • Oct 22
Analysts Lift Calumet Price Target After EPA Exemptions and Stable Margin Outlook
Narrative Update on Calumet: Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Calumet from $19.05 to $19.25 per share, citing minor improvements in discount rate assumptions and a stable outlook for profit margins. What's in the News Calumet received full or partial exemptions from the U.S. Environmental Protection Agency (EPA) for every small refinery exemption petition filed between 2019 and 2024.Aggiornamento dell'analisi • Oct 08
Renewable Trends And Specialties Will Shape Future Markets
Analysts have maintained their price target for Calumet at $19.05. They cite only minor adjustments to discount rate and valuation assumptions that do not materially alter their outlook for the company.Aggiornamento dell'analisi • Sep 24
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains stable, with both the discount rate and future P/E changing only marginally, resulting in an unchanged consensus price target of $19.05. What's in the News Calumet received full or partial EPA exemptions on all small refinery petitions from 2019–2024, reducing its accrued RIN liability from 396 million to 89 million RINs. The company was added to multiple Russell indexes, including Russell 2000, 2500, 3000, and their respective growth and value variants, increasing its visibility to index funds and institutional investors.Articolo di analisi • Sep 11
The Market Lifts Calumet, Inc. (NASDAQ:CLMT) Shares 33% But It Can Do More
Calumet, Inc. ( NASDAQ:CLMT ) shareholders would be excited to see that the share price has had a great month, posting...Aggiornamento dell'analisi • Sep 09
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains steady, with both the discount rate and future P/E experiencing only marginal adjustments, resulting in the consensus analyst price target holding firm at $19.05. What's in the News EPA granted Calumet full or partial exemptions on all small refinery petitions from 2019–2024, reducing RIN liability from 396 million to 89 million RINs. Calumet was added to numerous Russell indexes, including Russell 2000, 2500, 3000, and related growth/value/small cap completeness benchmarks, increasing its visibility to institutional investors.Aggiornamento dell'analisi • Aug 25
Renewable Trends And Specialties Will Shape Future Markets
Despite a notable increase in consensus revenue growth forecasts for Calumet, a decline in net profit margin offset the improvement, resulting in an unchanged analyst price target of $19.05. What's in the News Calumet added to multiple Russell indices, including the Russell 2000, 2500, and 3000, as well as corresponding Growth and Value subsets.Aggiornamento dell'analisi • Aug 10
Renewable Trends And Specialties Will Shape Future Markets
Despite materially improving revenue growth and net profit margin forecasts, Calumet’s consensus analyst price target remains unchanged at $18.80. What's in the News Calumet, Inc.Articolo di analisi • Jul 18
Potential Upside For Calumet, Inc. (NASDAQ:CLMT) Not Without Risk
With a price-to-sales (or "P/S") ratio of 0.3x Calumet, Inc. ( NASDAQ:CLMT ) may be sending bullish signals at the...Articolo di analisi • Jun 14
Is There An Opportunity With Calumet, Inc.'s (NASDAQ:CLMT) 48% Undervaluation?
Key Insights Calumet's estimated fair value is US$29.23 based on 2 Stage Free Cash Flow to Equity Calumet is estimated...Nuova analisi • May 28
Sustainable Aviation Fuel Expansion Will Capture Future Market Opportunity
Accelerated renewables expansion and regulatory tailwinds drive higher margins, premium pricing, and stronger earnings outlook, particularly for sustainable aviation fuel and renewable diesel.Seeking Alpha • Apr 24
Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update)
Summary Calumet Specialty Products is significantly undervalued, with a misunderstood market and a heavy short position that is likely to face a destructive end soon. First-quarter EBITDA estimates are strong, with potential for $90 million, and second-quarter projections are even higher due to favorable market conditions. Management is effectively managing leverage and cash flow, aiming to reduce debt significantly while maintaining positive cash flow and strong EBITDA generation. Despite risks from shorting and market uncertainties, the company's strategic moves and financial performance suggest a bullish outlook, making it a compelling buy. Read the full article on Seeking AlphaArticolo di analisi • Apr 17
It's Down 29% But Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks
Unfortunately for some shareholders, the Calumet, Inc. ( NASDAQ:CLMT ) share price has dived 29% in the last thirty...Seeking Alpha • Mar 11
Calumet's Businesses Firing Like A Cannon, Well, Close
Summary Calumet delivered in-line Q4 2024 results, with management's asset sales and cash generation efforts creating a favorable buying opportunity. Specialty EBITDA is projected to improve to the low $200 million range in 2025, driven by stronger Gulf Coast 2-1-1 spreads and operational efficiencies. The partial sale of Performance Brands for $110 million will be offset by operational efficiencies, maintaining EBITDA levels over the next two years. Montana Renewables' cost structure improvements and strategic expansions position it as a low-cost producer, with significant cash flow contributions expected to support debt reduction and growth initiatives. Read the full article on Seeking AlphaArticolo di analisi • Feb 04
Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks
Calumet, Inc.'s ( NASDAQ:CLMT ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Seeking Alpha • Jan 13
Update On Calumet, My Largest Investment
Summary Calumet, Inc. is undervalued and misunderstood, potentially reaching $30-$40 per share. The company’s Montana Renewables business reprocesses renewable feedstock into sustainable aviation fuel and renewable diesel, attracting ESG investors. Calumet secured $1.67 billion from the Department of Energy for its renewable fuels facility, enhancing its balance sheet and future expansion. Consider buying CLMT equity and writing January 2026 $30 calls to defer taxes to long-term capital gains in 2026. Read the full article on Seeking AlphaArticolo di analisi • Jan 12
The Returns On Capital At Calumet (NASDAQ:CLMT) Don't Inspire Confidence
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Seeking Alpha • Nov 17
Long-Term Investing In Calumet Specialty Products
Summary Investors should maintain a long-term vision despite short-term market fluctuations, as patience is crucial for substantial returns. Examples like Cirrus can help Calumet investors navigate investment strategies. The marketplace today requires a focus on 2-year, 5-year, and 20-year investment horizons to navigate risks effectively. Investors often get cranky during ugly years, but staying the course is essential for achieving long-term financial goals. Read the full article on Seeking AlphaArticolo di analisi • Nov 11
Is There An Opportunity With Calumet, Inc.'s (NASDAQ:CLMT) 26% Undervaluation?
Key Insights The projected fair value for Calumet is US$29.95 based on 2 Stage Free Cash Flow to Equity Current share...Articolo di analisi • Oct 16
There's No Escaping Calumet, Inc.'s (NASDAQ:CLMT) Muted Revenues Despite A 28% Share Price Rise
Calumet, Inc. ( NASDAQ:CLMT ) shares have continued their recent momentum with a 28% gain in the last month alone. The...Seeking Alpha • Oct 16
Calumet: A Compelling Energy Transition Turnaround
Summary Calumet Inc. is transitioning from an overleveraged oil refiner to a leading producer of Sustainable Airline Fuel (SAF), with potential for exceptional returns. The company converted from an MLP to a C-Corp to attract institutional investors and is restructuring its debt to improve financial stability. A prospective DOE loan and reduced capital expenditures could significantly enhance cash flow, aiding in debt reduction and boosting SAF production capacity. If successful, Calumet could achieve a market cap of $10 billion by 2027, driven by high growth in the SAF market and strategic debt management. Read the full article on Seeking AlphaPrevisioni di crescita degli utili e dei ricavi
| Data | Ricavi | Utili | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2028 | 4,288 | N/A | N/A | N/A | 1 |
| 12/31/2027 | 4,743 | 115 | N/A | 136 | 6 |
| 12/31/2026 | 4,245 | -17 | N/A | 94 | 5 |
| 12/31/2025 | 4,137 | -34 | 57 | 109 | N/A |
| 9/30/2025 | 4,048 | -37 | -76 | -11 | N/A |
| 6/30/2025 | 4,070 | -451 | -123 | -50 | N/A |
| 3/31/2025 | 4,178 | -343 | -56 | 18 | N/A |
| 12/31/2024 | 4,189 | -222 | -123 | -46 | N/A |
| 9/30/2024 | 4,216 | -230 | -134 | -50 | N/A |
| 6/30/2024 | 4,265 | -30 | -88 | 10 | N/A |
| 3/31/2024 | 4,150 | -12 | -244 | -82 | N/A |
| 12/31/2023 | 4,181 | 47 | -287 | -15 | N/A |
| 9/30/2023 | 4,204 | 20 | -458 | -57 | N/A |
| 6/30/2023 | 4,220 | -65 | -604 | -39 | N/A |
| 3/31/2023 | 4,626 | -58 | -523 | 77 | N/A |
| 12/31/2022 | 4,686 | -170 | -436 | 101 | N/A |
| 9/30/2022 | 4,553 | -179 | -288 | 137 | N/A |
| 6/30/2022 | 4,263 | -143 | -113 | 132 | N/A |
| 3/31/2022 | 3,646 | -205 | -140 | 3 | N/A |
| 12/31/2021 | 3,148 | -255 | -127 | -44 | N/A |
| 9/30/2021 | 2,836 | -250 | -75 | -32 | N/A |
| 6/30/2021 | 2,529 | -355 | -109 | -77 | N/A |
| 3/31/2021 | 2,176 | -275 | -3 | 32 | N/A |
| 12/31/2020 | 2,268 | -146 | 19 | 63 | N/A |
| 9/30/2020 | 2,489 | -103 | 41 | 103 | N/A |
| 6/30/2020 | 2,851 | -53 | 87 | 153 | N/A |
| 3/31/2020 | 3,294 | -73 | 84 | 145 | N/A |
| 12/31/2019 | 3,453 | -43 | 137 | 192 | N/A |
| 9/30/2019 | 3,526 | 14 | N/A | 258 | N/A |
| 6/30/2019 | 3,550 | 3 | N/A | 188 | N/A |
| 3/31/2019 | 3,598 | -31 | N/A | 122 | N/A |
| 12/31/2018 | 3,498 | -50 | N/A | 75 | N/A |
| 9/30/2018 | 3,533 | -86 | N/A | -52 | N/A |
| 6/30/2018 | 3,606 | -95 | N/A | -14 | N/A |
| 3/31/2018 | 3,628 | -34 | N/A | -5 | N/A |
| 12/31/2017 | 3,764 | -29 | N/A | -26 | N/A |
| 9/30/2017 | 3,702 | -58 | N/A | 20 | N/A |
| 6/30/2017 | 3,642 | -66 | N/A | 20 | N/A |
| 3/31/2017 | 3,648 | -222 | N/A | 20 | N/A |
| 12/31/2016 | 3,474 | -290 | N/A | 4 | N/A |
| 9/30/2016 | 3,551 | -363 | N/A | 62 | N/A |
| 6/30/2016 | 3,724 | -382 | N/A | 165 | N/A |
| 3/31/2016 | 3,907 | -239 | N/A | 231 | N/A |
| 12/31/2015 | 3,930 | -99 | N/A | 376 | N/A |
| 9/30/2015 | 4,654 | -101 | N/A | 464 | N/A |
| 6/30/2015 | 5,190 | -43 | N/A | 451 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Si prevede che CLMT diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 3.5% ).
Guadagni vs Mercato: Si prevede che CLMT diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.
Guadagni ad alta crescita: Si prevede CLMT diventerà redditizia nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di CLMT ( 5% all'anno) crescerà più lentamente rispetto al mercato US ( 11.5% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di CLMT ( 5% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Dati insufficienti per determinare se il Return on Equity di CLMT è previsto essere elevato tra 3 anni
Scoprire le aziende in crescita
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/07 10:15 |
| Prezzo dell'azione a fine giornata | 2026/05/07 00:00 |
| Utili | 2025/12/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Calumet, Inc. è coperta da 15 analisti. 6 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Richard Gross | Barclays |
| Conor Fitzpatrick | BofA Global Research |
| Jennifer Fitzpatrick | BofA Global Research |